Human NK Cell Development: One Road or Many?

Area of Science:

• Immunology
• Cell Biology
• Hematopoiesis

Background:

• Natural Killer (NK) cells are crucial immune cells that develop from CD34+ hematopoietic progenitors (HPCs).
• Current understanding suggests a linear model of NK cell development from common lymphocyte progenitors (CLPs) to CD56bright and then CD56dim subsets.
• This linear model is supported by in vivo and in vitro studies.

Purpose of the Study:

• To review and critically evaluate evidence supporting both linear and branched models of human NK cell development.
• To highlight the challenges in definitively concluding the NK cell developmental pathway.
• To inform in vitro differentiation strategies for generating NK cells for immunotherapy.

Main Methods:

• Literature review of studies on human NK cell development.
• Analysis of evidence supporting linear and branched developmental models.
• Examination of cell surface marker expression (CD34, CD56, CD94, CD16, KIR) during development.

Main Results:

• The prevailing linear model posits a continuum from CLPs to CD56bright and CD56dim NK cells.
• Evidence exists that challenges the linear model, suggesting a branched pathway with distinct precursor populations.
• Discrepancies in developmental models highlight the complexity of human NK cell ontogeny.

Conclusions:

• A definitive understanding of human NK cell development remains elusive.
• Both linear and branched models have supporting evidence, indicating a complex developmental process.
• Clarifying NK cell development is essential for optimizing NK cell-based immunotherapies.